APC c.517C>A ;(p.P173T)

Variant ID: 5-112111420-C-A

NM_000038.5(APC):c.517C>A;(p.P173T)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling.

Nature Medicine
Lu, Yuanyuan Y; Zhao, Xiaodi X; Liu, Qi Q; Li, Cunxi C; Graves-Deal, Ramona R; Cao, Zheng Z; Singh, Bhuminder B; Franklin, Jeffrey L JL; Wang, Jing J; Hu, Huaying H; Wei, Tianying T; Yang, Mingli M; Yeatman, Timothy J TJ; Lee, Ethan E; Saito-Diaz, Kenyi K; Hinger, Scott S; Patton, James G JG; Chung, Christine H CH; Emmrich, Stephan S; Klusmann, Jan-Henning JH; Fan, Daiming D; Coffey, Robert J RJ
Publication Date: 2017-11

Variant appearance in text: APC: P173T
PubMed Link: 29035371
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.

Plos Medicine
Hamblin, Angela A; Wordsworth, Sarah S; Fermont, Jilles M JM; Page, Suzanne S; Kaur, Kulvinder K; Camps, Carme C; Kaisaki, Pamela P; Gupta, Avinash A; Talbot, Denis D; Middleton, Mark M; Henderson, Shirley S; Cutts, Anthony A; Vavoulis, Dimitrios V DV; Housby, Nick N; Tomlinson, Ian I; Taylor, Jenny C JC; Schuh, Anna A
Publication Date: 2017-02

Variant appearance in text: APC: 517C>A
PubMed Link: 28196074
Variant Present in the following documents:
  • pmed.1002230.s004.xlsx, sheet 1
View BVdb publication page